Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News on Diabetes

Daily weight loss pill achieves main goal in late-stage trial

Data from an earlier study of the drug in patients without diabetes sent company shares tumbling

The Independent UK

Eli Lilly's Obesity Pill Shows Big Wins In Weight, Blood Sugar And Heart Risk Factors

Eli Lilly and Co. (NYSE:LLY) on Tuesday released topline results from the Phase 3 ATTAIN-2 trial, evaluating oral orforglipron in adults with obesity or overweight and type 2 diabetes.

Benzinga

True cost of the UK’s obesity crisis revealed – and how weight-loss jabs could be the answer

SPECIAL REPORT: The UK has an obesity epidemic, with levels having doubled since the 1990s. Could increasing the rollout of weight-loss drugs ease the burden on the overstretched NHS? Alicja Hagopian and Rebecca Thomas report

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Weight-loss drugs are a quick fix with long-term results

THE INDEPENDENT VIEW: Editorial: For those able to take them, weight-loss drugs can offer startling results in improved quality of life, and in relieving the pressure on the NHS and the British economy

The Independent UK

Amanda Bynes' New Look: Debuts Lip Fillers After Blepharoplasty and Ozempic Weight-Loss

Amanda Bynes debuts fuller lips following eyelid surgery and Ozempic weight loss, sharing her journey toward renewed confidence and a refreshed appearance.

International Business Times UK

Always Hungry? Try These 10 Foods That Contain More Protein Than Eggs, According to a Nutritionist

Stock your fridge with satiating goodness.

Marie Claire

OPINION - The soaring price of weight loss drugs could derail the NHS's obesity plan – unless they take this action

The list price for the most popular and effective weight loss injection (Mounjaro) in the UK has risen by almost three times, from £122 to £330 a month for the highest dose, as of September 1.

Evening Standard

Read news from The Economist, FT, and more,
with one subscription

Diabetes smartphone test could diagnose condition in under 10 minutes

The creators of the world-first app at diagnostics company PocDoc say the test could also save the NHS billions

The Independent UK

UK Pharmacists May Be Able to Prescribe Ozempic Very Soon - We Asked Over-Stretched Clinicians for Their Honest Thoughts

A good move or a damaging one?

Marie Claire

10 Photos Of Serena Williams' 'Zepbound Body' After Drastic Weight Loss - How Did It Work?

Serena Williams lost 31 pounds using Zepbound after traditional training failed, opening up about health, hormones, and her honest journey.

International Business Times UK

UK firms misleading parents with milk teeth autism treatment claims, report finds

Charity says it is ‘outrageous’ tooth stem cell procedures are being advertised with claims about ‘treating’ autism

The Guardian - UK

The supplement that could help with weight loss for people with diabetes

Turmeric and curcumin may offer modest benefits for weight management in people with prediabetes and type 2 diabetes, a new study found

The Independent UK

Women who give birth before 21 are at higher risk of these conditions

Early reproduction may come at a cost as new study identifies higher risk of health problems

The Independent UK

Diabetes patients could be offered weight loss jabs sooner in major shake-up

The changes will impact millions of people with type 2 diabetes in England in the biggest shake-up of care in a decade

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - AU

Continuous glucose monitors: should people who don’t live with diabetes be wearing them?

Gwyneth Paltrow and other celebrities and influencers are sporting CGMs, but counting your glucose levels provides little benefit if you don’t have diabetes

Benzinga

Like Eli Lilly, Viking Therapeutics' Oral Weight Loss Drug Disappoints, Stock Tanks

On Tuesday, Viking Therapeutics Inc. (NASDAQ:VKTX) released the much-awaited data from its Phase 2 trial of VK2735 pill, the company’s dual agonist of the glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors.

Evening Standard

Ozempic price slashed following Donald Trump's demands - will it impact the UK cost?

Novo Nordisk said it has no plans to rise UK prices, despite pressure from Trump

The Independent UK

Half-off Ozempic? US patients paying in cash can now buy the popular weight-loss drug for less

The drug is available as a weight-loss medication under the brand name Wegovy and will now also be sold directly to diabetes patients

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Vegas teachers are getting lapband surgery paid for if they don’t put weight back on

Over 50 teachers in the Clark County School District have taken advantage of the program, which reimburses the $5,000 copay for bariatric surgery if they keep the weight off for five years.

The Independent UK

New study finally busts health myth of much-loved tropical fruit

Clinical trials replaced breakfast bread with a mango and monitored glycemic responses

The Independent UK

Patients warned not to turn to fake weight loss jabs after UK Mounjaro price hike

Pharmacists fear rise in sale of dangerous counterfeit medicines as drugmaker triples price of prescription

The Independent UK

Millions of people ‘could be denied weight-loss jabs due to flawed NHS guidance’

NHS BMI measures ‘don’t work for around 3 million patients’, a health analyst has warned

The Independent UK

Mounjaro weight-loss drug price to almost triple in UK after Trump complaint

At least 500,000 people in the UK take either Mounjaro or Wegovy, another weight-loss jab, through private prescriptions

Evening Standard

Drug that slows onset of type 1 diabetes licensed for use in UK-first

The cost-effectiveness of the drug for NHS roll-out will now be assessed by the National Institute for Health and Care Excellence.

Benzinga

Eli Lilly To Raise Mounjaro Price In UK, Expands Obesity Drug Push In India

Eli Lilly and Co. (NYSE:LLY) will sharply increase the list price of its weight-loss and type 2 diabetes drug Mounjaro (tirzepatide) in the United Kingdom, while expanding its market presence in India with a new injector pen.

1 … 12 13 14 15

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the National Institute for Health and Care Excellence

28 stories

Zepbound

14 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.